With the acquisition of a leading scientific cannabinoid testing facility, BRITISH CANNABIS takes its track record for having the most rigorously tested CBD products in the market and amplifies it tenfold. This can strengthen confidence that consumers and business partners have in the reliability of cannabinoid products and medicines, – making sure that people get what they pay for.
Upholding Compliance & Quality: The acquisition ensures the continuous operation of PhytoVista Laboratories, one of the UK’s premier cannabinoid labs, a critical component for legal and regulatory compliance and consumer and patient safety within the industry.
Reliability and Assurance: As CBD products and medical cannabis grow wider acceptance amongst consumers, patients, and healthcare professionals, the accreditations held by PhytoVista Laboratories provide a critical layer of assurance and reliability. These standards enable providers and consumers to have faith in the accurate testing of THC and cannabinoid compositions, promoting compliance, quality, and trust.
Product Safety and Integrity: PhytoVista Laboratories is committed to confirming that cannabinoid products are devoid of harmful contaminants, pesticides, and microbial activity. Assurance of the quality and purity of CBD and medical cannabis products are essential for fostering and sustaining trust within the cannabis and plant medicine communities.
The Importance of the Acquisition:
- For UK Patients & Consumers: Ensures access to products that are verified to validated methods for purity and safety.
- For UK Businesses: Establishes a higher degree of confidence in verifying compliant and thoroughly tested cannabinoid products.
- For UK Medical Cannabis Providers: Provides a secondary, more robust set of quality and safety standards for CBPMs (Cannabis Based Prescription Medicines) services.
A Statement from PhytoVista Laboratories: Matthew Birt, the Director of PhytoVista Laboratories, comments, “This acquisition allows us to reinforce our dedication to maintaining the highest scientific and quality standards, enhancing the trust consumers, providers, and industry partners place in cannabinoid products.”
Future Vision: In partnership with PhytoVista Laboratories, BRITISH CANNABIS™ aspires to set unparalleled standards of purity and quality in the cannabinoid sector, contributing to the growing acceptance and trust in cannabis as a legal and effective natural medicine.
Commitment to Quality and Trust: We strive to forge an environment where quality and consumer trust are paramount, ensuring every product meets the highest standards of safety, purity, and compliance. Our collaborative effort is critical acceptance and establishing trust in cannabinoid-based remedies.
Services Offered by PhytoVista Laboratories:
- Cannabinoid Analysis: Delivering precision in testing CBD content and controlled substances in consumer products using the latest techniques.
- Diverse Product Testing: Undertaking examination of an array of products from oils to supplements, showcasing flexibility in testing protocols.
- Compliance Consultancy: Offering counsel on packaging and labelling to maximise product regulatory compliance and aid in acquiring requisite certifications.
- Stability Testing: Providing thorough evaluations to ascertain precise retail shelf lives for consumer products.
- Terpene Content Analysis: Implementing validated methods for accurate testing of over 20 individual terpenes.
- Product Development: From formulation consultancy to full compliance assurance for product specifications across brands and markets.
- Chem ID Integration: Integrating meticulous tracking and testing for origins and chemical data of regulated goods.
- Price and Service Guarantee: Offering competitive prices with guarantees on service timelines and resolutions for discrepancies and delays.
For additional information about our services and initiatives, please contact our UK headquarters at +44 (0)1373470418 or email email@example.com. Discover more about our transformative work at PhytoVista Laboratories.
- 3 main contributors to the entourage effect for cannabis consumers to consider
- Medical cannabis doesn’t impair cognitive function – study
- Ukraine’s medical cannabis legalisation delayed by opponents
- Cannabis more ‘advantageous’ than conventional sleep aids
- Four20 Medical Cannabis Products Launched in the UK via Rokshaw
- The potential of Medical Cannabis in diabetes management
- Cannabis explained6 months ago
What is HHC? Its effects, safety and legal status in Europe
- News4 months ago
NHS approves major clinical trial on cannabis medicines and chronic pain
- News6 months ago
UK patient secures first NHS reimbursement for cannabis flowers
- Industry6 months ago
UK’s first ‘own your grow’ initiative gives patients chance to invest in cannabis
- Advocacy5 months ago
Inside a UK cannabis club: changing lives, tackling stigma, building community
- News4 months ago
UK research finds GP support for cannabis as an alternative to opioids for chronic pain
- Industry4 months ago
‘Landmark’ ruling gives hope for UK CBD flower businesses
- Industry6 months ago
Hemp tea no longer classed as Novel Food under EU law